DE4133694C2
(de)
*
|
1991-10-11 |
1993-10-07 |
Fresenius Ag |
Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
|
WO1994022313A1
(en)
*
|
1993-04-01 |
1994-10-13 |
Ici Australia Operations Proprietary Limited |
Pan release agent
|
WO1994028732A1
(en)
*
|
1993-06-07 |
1994-12-22 |
Ici Australia Operations Proprietary Limited |
Reduction of moisture loss from plant and animal matter
|
US5716614A
(en)
*
|
1994-08-05 |
1998-02-10 |
Molecular/Structural Biotechnologies, Inc. |
Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
|
ATE167983T1
(de)
*
|
1994-10-05 |
1998-07-15 |
Milupa Gmbh & Co Kg |
Phospholipidhaltige fettmischung mit lcp- fettsäuren
|
JPH0987176A
(ja)
*
|
1995-09-26 |
1997-03-31 |
Shiseido Co Ltd |
糸球体腎炎抑制剤
|
KR100293297B1
(ko)
*
|
1995-11-24 |
2001-08-07 |
씨.지. 온닝크 |
어유기재조성물
|
IT1277953B1
(it)
*
|
1995-12-21 |
1997-11-12 |
Sigma Tau Ind Farmaceuti |
Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
|
DE19608137A1
(de)
*
|
1996-03-02 |
1997-09-04 |
Meyer Lucas Gmbh & Co |
Lipid-Zubereitungen für diätetische Zwecke
|
DE19644518A1
(de)
*
|
1996-10-25 |
1998-04-30 |
Nutricia Nv |
Wässrige Fettemulsion, diese enthaltende Nahrung und deren Verwendung
|
US6344482B1
(en)
*
|
1997-04-23 |
2002-02-05 |
Andrew L. Stoll |
Omega-3 fatty acids in the treatment of bipolar disorder
|
US6852870B2
(en)
*
|
1999-03-22 |
2005-02-08 |
Andrew Stoll |
Omega-3 fatty acids in the treatment of depression
|
US7906153B2
(en)
*
|
1998-04-08 |
2011-03-15 |
Theta Biomedical Consulting & Development Co., Inc. |
Anti-inflammatory compositions for treating multiple sclerosis
|
US5955102A
(en)
|
1998-09-04 |
1999-09-21 |
Amway Corporation |
Softgel capsule containing DHA and antioxidants
|
CO5111023A1
(es)
|
1998-12-31 |
2001-12-26 |
Kimberly Clark Co |
Composicion de articulo absorbente y metodo para usarla para secuestrar irritantes de la piel
|
GB9901809D0
(en)
|
1999-01-27 |
1999-03-17 |
Scarista Limited |
Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
|
US8753675B1
(en)
*
|
2000-01-20 |
2014-06-17 |
Raj K. Chopra |
Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
|
CA2304906A1
(en)
*
|
2000-04-07 |
2001-10-07 |
1411198 Ontario Limited |
13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
|
AU2001264079A1
(en)
*
|
2000-06-14 |
2001-12-24 |
William Leslie Porter |
Lipids for modulating immune response
|
GB0014437D0
(en)
*
|
2000-06-14 |
2000-08-09 |
Porter William L |
Immune response stimulation
|
AU2002241738A1
(en)
*
|
2000-12-29 |
2002-07-16 |
The Trustees Of Columbia University In The City Of New York |
Use of iv emulsions with different triglyceride composition, particle size and apolipoprotein e for targeted tissue delivery of hydrophobic compounds
|
MX281182B
(es)
*
|
2001-05-14 |
2010-11-22 |
Martek Biosciences Boulder Corp |
Produccion y uso de una fraccion rica en lipidos polares, que contienen acidos grasos altamente insaturados omega-3 y/u omega-6, procedentes de microbios, de semillas de plantas y de organismos marinos geneticamente modificados.
|
EP1279400A1
(en)
*
|
2001-07-25 |
2003-01-29 |
Target Hit sa |
Modifying the fatty acid composition of cell membranes of organs and tissues
|
CN1561218A
(zh)
*
|
2001-07-27 |
2005-01-05 |
努特里奇亚有限公司 |
用于预防和/或治疗败血症的肠道组合物
|
WO2003011873A2
(en)
|
2001-07-27 |
2003-02-13 |
Neptune Technologies & Bioressources Inc. |
Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
|
WO2003017945A2
(en)
*
|
2001-08-24 |
2003-03-06 |
Martek Biosciences Boulder Corporation |
Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
|
CN101072509A
(zh)
*
|
2002-03-08 |
2007-11-14 |
孟山都技术有限公司 |
炎症的治疗和预防
|
WO2004047554A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Phares Pharmaceutical Research N.V. |
Marine lipid compositions
|
ITMI20030036A1
(it)
*
|
2003-01-13 |
2004-07-14 |
Hunza Di Pistolesi Elvira & C S A S |
Preparazioni farmacologiche o dietetiche costituite da
|
US8633246B2
(en)
|
2003-08-11 |
2014-01-21 |
Hill's Pet Nutrition, Inc. |
Omega-3 fatty acids for osteoarthritis
|
US8633247B2
(en)
*
|
2003-08-11 |
2014-01-21 |
Hill's Pet Nutrition, Inc. |
Method for decreasing cartilage damage in dogs
|
ES2229935B1
(es)
*
|
2003-10-10 |
2006-10-01 |
Universitat De Les Illes Balears |
Utilizacion del acido hidroxioleico y compuestos analagos del mismo como aditivos alimentarios funcionales.
|
US7935365B2
(en)
|
2003-10-22 |
2011-05-03 |
Enzymotec, Ltd. |
Glycerophospholipids for the improvement of cognitive functions
|
US8052992B2
(en)
|
2003-10-22 |
2011-11-08 |
Enzymotec Ltd. |
Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
|
US20050130937A1
(en)
|
2003-10-22 |
2005-06-16 |
Enzymotec Ltd. |
Lipids containing omega-3 and omega-6 fatty acids
|
CA2545752C
(en)
*
|
2003-11-12 |
2013-03-26 |
Children's Medical Center Corporation |
Treatment and prevention of liver disease associated with parenteral nutrition (pn)
|
US8075910B2
(en)
*
|
2004-05-20 |
2011-12-13 |
Pbm Pharmaceuticals, Inc. |
Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
|
MX263572B
(es)
*
|
2004-06-10 |
2009-01-07 |
Kellog Co |
Aplicacion topica de aceites marinos a alimentos.
|
MXPA06015203A
(es)
*
|
2004-07-01 |
2007-03-27 |
Nestec Sa |
Formulacion de dieta para osteoartritis canina.
|
CN101179954A
(zh)
*
|
2004-11-12 |
2008-05-14 |
荷兰纽迪希亚公司 |
用于快速减弱炎症反应的含有蛋白质和脂质的食品组合物
|
FR2880538B1
(fr)
*
|
2005-01-07 |
2008-12-26 |
Polaris Soc Par Actions Simpli |
Composition cosmetique et cosmeceutique a base d'huiles de poissons, de phospholipides d'origine marine avec ou sans huile de pepins de franboise
|
GB0506788D0
(en)
*
|
2005-04-04 |
2005-05-11 |
Biosea Man As |
Process
|
WO2007058523A1
(en)
*
|
2005-11-17 |
2007-05-24 |
N.V. Nutricia |
Composition with docosapentaenoic acid
|
ES2277557B1
(es)
*
|
2005-12-21 |
2008-07-01 |
Proyecto Empresarial Brudy, S.L. |
Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
|
JP2009523414A
(ja)
*
|
2005-12-21 |
2009-06-25 |
ブルーディ、テクノロジー、ソシエダッド、リミターダ |
細胞の酸化的損傷に関連した病変を治療するためのdha、epaまたはdha由来のepaの使用
|
US20070225370A1
(en)
*
|
2006-03-21 |
2007-09-27 |
Joar Opheim |
Nutritional Compositions and Methods
|
WO2008149177A2
(en)
*
|
2006-05-05 |
2008-12-11 |
Natural Asa |
Marine lipid compositions and uses thereof
|
US20080044487A1
(en)
|
2006-05-05 |
2008-02-21 |
Natural Asa |
Anti-inflammatory properties of marine lipid compositions
|
US20100048705A1
(en)
*
|
2006-11-09 |
2010-02-25 |
Children's Medical Center Corporation |
Methods of treating and preventing neovascularization with omega-3 polyunsaturated fatty acids
|
US20090018870A1
(en)
*
|
2006-12-01 |
2009-01-15 |
Joseph Thomas Weishaar |
Method for Preventing Chronic Disease
|
KR101394594B1
(ko)
*
|
2007-02-15 |
2014-05-14 |
슈 생-쥐스땡 |
골 재흡수 및 골 형성 간의 불균형을 보정하는 방법 및 이를 위한 키트 및 조성물
|
CA2682068C
(en)
|
2007-03-28 |
2017-11-28 |
Aker Biomarine Asa |
Bioeffective krill oil compositions
|
US8697138B2
(en)
|
2007-03-28 |
2014-04-15 |
Aker Biomarine As |
Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
|
WO2008119170A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Chu Sainte Justine |
Method of determining risk of scoliosis
|
US20110065673A1
(en)
*
|
2007-05-11 |
2011-03-17 |
Bizen Chemical Co., Ltd. |
Novel leukotriene receptor agonist
|
US20100226977A1
(en)
*
|
2007-08-29 |
2010-09-09 |
Aker Biomarine Asa |
Low viscosity phospholipid compositions
|
CA2697730C
(en)
*
|
2007-08-29 |
2014-04-08 |
Aker Biomarine Asa |
A new method for making krill meal
|
US20090099261A1
(en)
*
|
2007-09-25 |
2009-04-16 |
Isi Brands Inc. |
Omega-3 mixtures
|
US8343753B2
(en)
*
|
2007-11-01 |
2013-01-01 |
Wake Forest University School Of Medicine |
Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
|
GB0808479D0
(en)
*
|
2008-05-09 |
2008-06-18 |
Uni I Oslo |
Topical compositions
|
JP5924834B2
(ja)
|
2008-09-02 |
2016-05-25 |
アマリン ファーマシューティカルズ アイルランド リミテッド |
エイコサペンタエン酸およびニコチン酸を含む製薬組成物ならびにこの製薬組成物を用いる方法
|
PT2596786T
(pt)
|
2009-02-10 |
2020-03-04 |
Amarin Pharmaceuticals Ie Ltd |
Utilização de éster etílico de ácido eicosapentaenoico para tratamento de hipertrigliceridemia
|
US8372812B2
(en)
*
|
2009-02-26 |
2013-02-12 |
Aker Biomarine Asa |
Phospholipid and protein tablets
|
AU2010241571B2
(en)
|
2009-04-29 |
2014-06-26 |
Amarin Pharmaceuticals Ireland Limited |
Stable pharmaceutical composition and methods of using same
|
CN106822080A
(zh)
|
2009-04-29 |
2017-06-13 |
阿马里纳药物爱尔兰有限公司 |
含有epa和心血管剂的药物组合物以及使用其的方法
|
CA3129996A1
(en)
|
2009-06-15 |
2010-12-23 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
|
NO333013B1
(no)
|
2009-07-06 |
2013-02-18 |
Smartfish As |
Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
|
NZ599061A
(en)
|
2009-09-23 |
2014-05-30 |
Amarin Pharmaceuticals Ie Ltd |
Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
|
CA2779162C
(en)
|
2009-10-29 |
2018-02-06 |
Acasti Pharma, Inc. |
Concentrated therapeutic phospholipid compositions
|
US8974818B2
(en)
*
|
2010-01-20 |
2015-03-10 |
Henry Wu |
Custom-formulated phospholipid microbubbles and methods and uses thereof
|
US20110200644A1
(en)
*
|
2010-02-18 |
2011-08-18 |
Martek Biosciences Corporation |
DHA Ester Emulsions
|
US20110206741A1
(en)
*
|
2010-02-18 |
2011-08-25 |
Martek Biosciences Corporation |
DHA Triglyceride Emulsions
|
US20110200645A1
(en)
*
|
2010-02-18 |
2011-08-18 |
Martek Biosciences Corporation |
DHA Free Fatty Acid Emulsions
|
US20110223246A1
(en)
*
|
2010-03-10 |
2011-09-15 |
Joar Opheim |
Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source
|
EP2646013A4
(en)
|
2010-11-29 |
2014-03-26 |
Amarin Pharma Inc |
COMPOSITION WITH LOW IMPACT EFFECT AND METHOD FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES IN A PATIENT WITH FISH ALLERGY / SENSITIVITY
|
US11712429B2
(en)
|
2010-11-29 |
2023-08-01 |
Amarin Pharmaceuticals Ireland Limited |
Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
|
US20210176999A1
(en)
|
2011-04-17 |
2021-06-17 |
Omega Foods, LLC |
Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
|
US8895074B2
(en)
|
2011-06-15 |
2014-11-25 |
Stable Solutions Llc |
Therapeutic application of parenteral krill oil
|
CA2838312C
(en)
*
|
2011-06-15 |
2019-01-08 |
Stable Solutions Llc |
Therapeutic application of parenteral krill oil
|
US10052352B2
(en)
|
2011-06-15 |
2018-08-21 |
Stable Solutions Llc |
Therapeutic application of parenteral krill oil
|
US10383839B2
(en)
|
2011-06-30 |
2019-08-20 |
Johnson & Johnson Vision Care, Inc. |
Esters for treatment of ocular inflammatory conditions
|
WO2013033618A1
(en)
|
2011-09-02 |
2013-03-07 |
Arctic Nutrition As |
Lipid compositions with high dha content
|
US11291643B2
(en)
|
2011-11-07 |
2022-04-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
US20130131170A1
(en)
|
2011-11-07 |
2013-05-23 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating hypertriglyceridemia
|
WO2013103958A1
(en)
|
2012-01-06 |
2013-07-11 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
|
WO2013142482A1
(en)
|
2012-03-20 |
2013-09-26 |
Particle Dynamics International, Llc |
Gelling agent-based dosage form
|
US20150110866A1
(en)
*
|
2012-05-22 |
2015-04-23 |
Harold Gordon Cave |
Complexes and compositions containing curcumin
|
SG10201913645RA
(en)
|
2012-06-29 |
2020-03-30 |
Amarin Pharmaceuticals Ie Ltd |
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
|
EP2890689B1
(en)
|
2012-08-29 |
2018-08-08 |
Université du Québec à Chicoutimi |
Dihydrochalcone derivatives and their use as antibiotic agents
|
US20150265566A1
(en)
|
2012-11-06 |
2015-09-24 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
|
US9814733B2
(en)
|
2012-12-31 |
2017-11-14 |
A,arin Pharmaceuticals Ireland Limited |
Compositions comprising EPA and obeticholic acid and methods of use thereof
|
US20140187633A1
(en)
|
2012-12-31 |
2014-07-03 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
|
US9452151B2
(en)
|
2013-02-06 |
2016-09-27 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing apolipoprotein C-III
|
US9624492B2
(en)
|
2013-02-13 |
2017-04-18 |
Amarin Pharmaceuticals Ireland Limited |
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
|
US9662307B2
(en)
|
2013-02-19 |
2017-05-30 |
The Regents Of The University Of Colorado |
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
|
US9283201B2
(en)
|
2013-03-14 |
2016-03-15 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for treating or preventing obesity in a subject in need thereof
|
US20140271841A1
(en)
|
2013-03-15 |
2014-09-18 |
Amarin Pharmaceuticals Ireland Limited |
Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
|
US10966968B2
(en)
|
2013-06-06 |
2021-04-06 |
Amarin Pharmaceuticals Ireland Limited |
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
|
AU2014203179C1
(en)
|
2013-06-14 |
2017-05-04 |
Aker Biomarine Antarctic As |
Lipid extraction processes
|
EP3011332B1
(en)
|
2013-06-17 |
2019-09-18 |
CHU Sainte-Justine |
New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis
|
KR20160020554A
(ko)
|
2013-06-17 |
2016-02-23 |
슈 생-쥐스땡 |
척추측만 개체의 세포에서 gipcr 신호전달을 증가시키는 방법
|
AU2014284075A1
(en)
|
2013-06-17 |
2016-01-07 |
Chu Sainte-Justine |
Gi protein phosphorylation as marker for scoliosis and scoliosis progression, methods of increasing GiPCR signaling in scoliotic subjects
|
EP2826384A1
(de)
|
2013-07-16 |
2015-01-21 |
Evonik Industries AG |
Verfahren zur Trocknung von Biomasse
|
CA2918291C
(en)
|
2013-07-22 |
2022-12-06 |
Universite Du Quebec A Chicoutimi |
Use of plant extracts against herpes simplex virus
|
US20150065572A1
(en)
|
2013-09-04 |
2015-03-05 |
Amarin Pharmaceuticals Ireland Limited |
Methods of treating or preventing prostate cancer
|
US9585859B2
(en)
|
2013-10-10 |
2017-03-07 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
|
US9549937B2
(en)
|
2013-12-05 |
2017-01-24 |
Burvia, LLC. |
Composition containing phospholipid-DHA and folate
|
US9216199B2
(en)
|
2013-12-05 |
2015-12-22 |
Buriva, LLC |
Nutritional supplement containing phospholipid-DHA derived from eggs
|
US9233114B2
(en)
|
2013-12-05 |
2016-01-12 |
Buriva, LLC |
Dietary supplement containing phospholipid-DHA derived from eggs
|
US9610302B2
(en)
|
2013-12-05 |
2017-04-04 |
Buriva, LLC. |
Composition containing phospholipid-DHA and B vitamins
|
GB201400431D0
(en)
|
2014-01-10 |
2014-02-26 |
Aker Biomarine As |
Phospholipid compositions and their preparation
|
US10561631B2
(en)
|
2014-06-11 |
2020-02-18 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing RLP-C
|
US10172818B2
(en)
|
2014-06-16 |
2019-01-08 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
BR112017006838B1
(pt)
|
2014-10-02 |
2021-07-06 |
Evonik Operations Gmbh |
Processo para produzir um alimento para animais compreendendo biomassa contendo pufa, alimento para animais e método para criar animais
|
WO2016050556A1
(de)
|
2014-10-02 |
2016-04-07 |
Evonik Degussa Gmbh |
Verfahren zur anzucht von tieren
|
US11464244B2
(en)
|
2014-10-02 |
2022-10-11 |
Evonik Operations Gmbh |
Feedstuff of high abrasion resistance and good stability in water, containing PUFAs
|
BR112017006834B1
(pt)
|
2014-10-02 |
2022-04-26 |
Evonik Operations Gmbh |
Processo para a preparação de um alimento para animais compreendendo pufas, produto extrudado de alimento para animais e método de criação de animais
|
EP3256003B1
(en)
|
2015-02-11 |
2022-11-09 |
Aker Biomarine Antarctic AS |
Lipid extraction processes
|
BR112017017310B1
(pt)
|
2015-02-11 |
2022-07-26 |
Aker Biomarine Antarctic As |
Composições lipídicas e suplemento alimentar ou nutricional, alimento médico ou funcional e veículo de liberação oral compreendendo as ditas composições
|
CA2980043C
(en)
*
|
2015-03-19 |
2023-03-21 |
Arctic Nutrition As |
Methods for obtaining phospholipids and compositions thereof
|
US10406130B2
(en)
|
2016-03-15 |
2019-09-10 |
Amarin Pharmaceuticals Ireland Limited |
Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
|
TW201900160A
(zh)
|
2017-05-19 |
2019-01-01 |
愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 |
用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
|
AU2018273411B2
(en)
|
2017-05-25 |
2022-12-01 |
The Governors Of The University Of Alberta |
Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
|
WO2019032959A1
(en)
|
2017-08-10 |
2019-02-14 |
The Children's Medical Center Corporation |
METHODS AND COMPOSITIONS RELATING TO EMULSIONS COMPRISING FISH OIL AND / OR OMEGA-3 FATTY ACIDS
|
US11058661B2
(en)
|
2018-03-02 |
2021-07-13 |
Amarin Pharmaceuticals Ireland Limited |
Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
|
MA51765A
(fr)
|
2018-09-24 |
2020-12-16 |
Amarin Pharmaceuticals Ie Ltd |
Procédés de réduction du risque d'événements cardiovasculaires chez un sujet
|
CN109527123A
(zh)
*
|
2018-12-14 |
2019-03-29 |
大连大学 |
一种对慢性肠炎具有改善作用的调和油
|
KR20240012390A
(ko)
|
2021-04-21 |
2024-01-29 |
애머린 파마슈티칼스 아일랜드 리미티드 |
심부전의 위험을 감소시키는 방법
|
WO2024057117A1
(en)
|
2022-09-14 |
2024-03-21 |
Societe Des Produits Nestle Sa |
Compositions and methods utilizing southern ocean mackerel oil for providing health benefits in an animal
|